Disposition of 13508 shares by Loscalzo Joseph of Ionis Pharmaceuticals at 37.861 subject to Rule 16b-3
0P000070H9 | CAD 54.52 0.04 0.07% |
About 62% of CI Global's investor base is looking to short. The analysis of overall sentiment of trading CI Global Health fund suggests that many investors are alarmed at this time. The current market sentiment, together with CI Global's historical and current headlines, can help investors time the market. In addition, many technical investors use CI Global Health fund news signals to limit their universe of possible portfolio assets.
0P000070H9 |
Filed transaction by Ionis Pharmaceuticals Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at investing.com
CI Global Fundamental Analysis
We analyze CI Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CI Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CI Global based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
CI Global is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
CI Global Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CI Global fund to make a market-neutral strategy. Peer analysis of CI Global could also be used in its relative valuation, which is a method of valuing CI Global by comparing valuation metrics with similar companies.
Peers
CI Global Related Equities
HIG | Global Healthcare | 0.37 | ||||
0P000070I2 | CI Global | 0.17 | ||||
0P0001D8QF | BMO Concentrated | 0.05 | ||||
0P000070HA | CI Global | 0.18 |
Other Information on Investing in 0P000070H9 Fund
CI Global financial ratios help investors to determine whether 0P000070H9 Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 0P000070H9 with respect to the benefits of owning CI Global security.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |